Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vaccine

• Publication date

  2011-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.04.088PMID 21565241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.

  2011cited by this paper
• Immunopotentiation of live brucellosis vaccine by adjuvants.

  2010cited by this paper
• Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge

  2010cited by this paper
• Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides

  2010cited by this paper
• Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

  2008cited by this paper
• Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.

  2008cited by this paper
• Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

  2008cited by this paper
• Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model.

  2007cited by this paper
• Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

  2007cited by this paper
• Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.

  2007cited by this paper
• Comparison of Protective Efficacy of Subcutaneous versus Intranasal Immunization of Mice with a Brucella melitensis Lipopolysaccharide Subunit Vaccine

  2006cited by this paper
• Brucella abortusd-alanyl-D-alanine carboxypeptidase contributes to its intracellular replication and resistance against nitric oxide.

  2006cited by this paper
• Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.

  2006cited by this paper
• Completion of the Genome Sequence of Brucella abortus and Comparison to the Highly Similar Genomes of Brucella melitensis and Brucella suis

  2005cited by this paper
• An RNA Vaccine Based on Recombinant Semliki Forest Virus Particles Expressing the Cu,Zn Superoxide Dismutase Protein of Brucella abortus Induces Protective Immunity in BALB/c Mice

  2005cited by this paper
• A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection against B. melitensis and B. ovis Infection by Eliciting a Specific Cytotoxic Response

  2005cited by this paper
• Intraspleen Delivery of a DNA Vaccine Coding for Superoxide Dismutase (SOD) of Brucella abortus Induces SOD-Specific CD4+ and CD8+ T Cells

  2004cited by this paper
• Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.

  2003cited by this paper
• A DNA Vaccine Encoding Cu,Zn Superoxide Dismutase of Brucella abortus Induces Protective Immunity in BALB/c Mice

  2003cited by this paper
• Brucella Evades Macrophage Killing via VirB-dependent Sustained Interactions with the Endoplasmic Reticulum

  2003cited by this paper
• Quantification of Cytokine Gene Expression Using an Economical Real‐Time Polymerase Chain Reaction Method Based on SYBR® Green I

  2003cited by this paper
• Interleukin‐18

  2003cited by this paper
• The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts

  2002cited by this paper
• A DNA Vaccine Encoding Lumazine Synthase from Brucella abortus Induces Protective Immunity in BALB/c Mice

  2002cited by this paper
• Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens

  2002cited by this paper
• Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation.

  2002cited by this paper
• Designing immune responses with genetic immunization and immunostimulatory DNA sequences.

  2001cited by this paper
• The genome sequence of the facultative intracellular pathogen Brucella melitensis

  2001cited by this paper
• Induction of Immune Response in BALB/c Mice with a DNA Vaccine Encoding Bacterioferritin or P39 ofBrucella spp

  2001cited by this paper
• Liposome mediated antigen delivery leads to induction of CD8+ T lymphocyte and antibody responses against the V3 loop region of HIV gp120.

  2001cited by this paper
• Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection.

  2001cited by this paper
• Immune control of Brucella abortus 2308 infections in BALB/c mice.

  2001cited by this paper
• Overexpression of Protective Antigen as a Novel Approach To Enhance Vaccine Efficacy of Brucella abortusStrain RB51

  2000cited by this paper
• IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma.

  2000cited by this paper
• Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation1

  2000cited by this paper
• IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6

  2000cited by this paper
• Identification and partial characterisation of a new protective antigen of Brucella abortus.

  2000cited by this paper
• IFN-γ-Inducing Factor (IL-18) Increases Allergic Sensitization, Serum IgE, Th2 Cytokines, and Airway Eosinophilia in a Mouse Model of Allergic Asthma1

  2000cited by this paper
• IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

  1999cited by this paper
• Vaccination with Live Escherichia coli ExpressingBrucella abortus Cu/Zn Superoxide Dismutase Protects Mice against Virulent B. abortus

  1999cited by this paper
• A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement.

  1999cited by this paper
• Quantitative assessment by flow cytometry of T-lymphocytes producing antigen-specific gamma-interferon in Brucella immune cattle.

  1998cited by this paper
• Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response.

  1997cited by this paper
• Brucellosis: an overview.

  1997cited by this paper
• Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.

  1996cited by this paper
• Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.

  1996cited by this paper
• Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.

  1992cited by this paper
• Biological properties of RB51; a stable rough strain of Brucella abortus.

  1991cited by this paper
• A protein isolated from Brucella abortus is a Cu-Zn superoxide dismutase.

  1990cited by this paper
• Differential reactivity of bovine lymphocytes to species of Brucella.

  1990cited by this paper
• Cloning, expression, and occurrence of the Brucella Cu-Zn superoxide dismutase

  1990cited by this paper
• Effect of reduced dosages of Brucella abortus strain 19 in cattle vaccinated as yearlings.

  1979cited by this paper

• Brucella melitensis Vaccines: A Systematic Review

  2023cites this paper
• Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice

  2023cites this paper
• Biosynthesis and Immunological Evaluation of a Dual-Antigen Nanoconjugate Vaccine against Brucella melitensis

  2023cites this paper
• Evaluation of Brucellosis Vaccines: A Comprehensive Review

  2022cites this paper
• Prophylactic vaccine delivery systems against epidemic infectious diseases

  2021cites this paper
• Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice

  2018cites this paper
• Development and trial of vaccines against Brucella

  2017cites this paper
• Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.

  2016cites this paper
• Meta-Analysis and Advancement of Brucellosis Vaccinology

  2016cites this paper
• Vaccines and Vaccine Candidates against Brucellosis

  2016cites this paper
• Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus

  2015cites this paper
• Immunotherapy for Bone and Soft Tissue Sarcomas

  2015cites this paper
• Recent advances in Brucella abortus vaccines

  2015cites this paper
• Liposomes as vaccine delivery systems: a review of the recent advances

  2014cites this paper
• Medical Countermeasures, Protection and Treatment, against the Brucella species

  2013cites this paper
• Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.

  2012cites this paper